X-30251271-G-A
Position:
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 0P and 4B. BS2
The NM_177404.3(MAGEB1):c.778G>A(p.Val260Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000118 in 1,098,230 control chromosomes in the GnomAD database, with no homozygous occurrence. There are 3 hemizygotes in GnomAD. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Genomes: not found (cov: 24)
Exomes 𝑓: 0.000012 ( 0 hom. 3 hem. )
Consequence
MAGEB1
NM_177404.3 missense
NM_177404.3 missense
Scores
1
8
8
Clinical Significance
Conservation
PhyloP100: 0.407
Genes affected
MAGEB1 (HGNC:6808): (MAGE family member B1) This gene is a member of the MAGEB gene family. The members of this family have their entire coding sequences located in the last exon, and the encoded proteins show 50 to 68% sequence identity to each other. The promoters and first exons of the MAGEB genes show considerable variability, suggesting that the existence of this gene family enables the same function to be expressed under different transcriptional controls. This gene is localized in the DSS (dosage-sensitive sex reversal) critical region, and expressed in testis and in a significant fraction of tumors of various histological types. This gene and other MAGEB members are clustered on chromosome Xp22-p21. Multiple alternatively spliced transcript variants encoding the same protein have been found for this gene, however, the full length nature of some variants has not been defined. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Likely_benign. Variant got -4 ACMG points.
BS2
High Hemizygotes in GnomAdExome4 at 3 gene
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
MAGEB1 | NM_177404.3 | c.778G>A | p.Val260Met | missense_variant | 2/2 | ENST00000397548.4 | NP_796379.1 | |
MAGEB1 | NM_002363.5 | c.778G>A | p.Val260Met | missense_variant | 4/4 | NP_002354.2 | ||
MAGEB1 | NM_177415.3 | c.778G>A | p.Val260Met | missense_variant | 3/3 | NP_803134.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
MAGEB1 | ENST00000397548.4 | c.778G>A | p.Val260Met | missense_variant | 2/2 | 1 | NM_177404.3 | ENSP00000380681.2 | ||
MAGEB1 | ENST00000378981.8 | c.778G>A | p.Val260Met | missense_variant | 4/4 | 1 | ENSP00000368264.3 | |||
MAGEB1 | ENST00000397550.6 | c.778G>A | p.Val260Met | missense_variant | 3/3 | 1 | ENSP00000380683.1 |
Frequencies
GnomAD3 genomes Cov.: 24
GnomAD3 genomes
Cov.:
24
GnomAD3 exomes AF: 0.0000109 AC: 2AN: 183507Hom.: 0 AF XY: 0.0000147 AC XY: 1AN XY: 67937
GnomAD3 exomes
AF:
AC:
2
AN:
183507
Hom.:
AF XY:
AC XY:
1
AN XY:
67937
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.0000118 AC: 13AN: 1098230Hom.: 0 Cov.: 31 AF XY: 0.00000825 AC XY: 3AN XY: 363584
GnomAD4 exome
AF:
AC:
13
AN:
1098230
Hom.:
Cov.:
31
AF XY:
AC XY:
3
AN XY:
363584
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome Cov.: 24
GnomAD4 genome
Cov.:
24
Bravo
AF:
ExAC
AF:
AC:
1
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:1
Revision: criteria provided, single submitter
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 26, 2024 | The c.778G>A (p.V260M) alteration is located in exon 4 (coding exon 1) of the MAGEB1 gene. This alteration results from a G to A substitution at nucleotide position 778, causing the valine (V) at amino acid position 260 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Uncertain
BayesDel_addAF
Benign
T
BayesDel_noAF
Benign
CADD
Benign
DANN
Uncertain
DEOGEN2
Benign
T;T;T
FATHMM_MKL
Benign
N
LIST_S2
Uncertain
.;D;.
M_CAP
Uncertain
D
MetaRNN
Uncertain
D;D;D
MetaSVM
Benign
T
MutationAssessor
Pathogenic
H;H;H
PrimateAI
Benign
T
PROVEAN
Uncertain
N;N;N
REVEL
Benign
Sift
Uncertain
D;D;D
Sift4G
Uncertain
D;D;D
Polyphen
D;D;D
Vest4
MutPred
Loss of catalytic residue at V260 (P = 0.0473);Loss of catalytic residue at V260 (P = 0.0473);Loss of catalytic residue at V260 (P = 0.0473);
MVP
MPC
ClinPred
D
GERP RS
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at